Unicycive Therapeutics (UNCY) Institutional Ownership $0.61 -0.01 (-1.98%) Closing price 04:00 PM EasternExtended Trading$0.61 0.00 (0.00%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Unicycive Therapeutics (NASDAQ:UNCY)CurrentInstitutional OwnershipPercentage40.42%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$23.10MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$2.01M Get UNCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Unicycive Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data UNCY Institutional Buying and Selling by Quarter Remove Ads Unicycive Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Octagon Capital Advisors LP10,000,000$7.94M1.3%+16.8%9.634% 2/17/2025 Alyeska Investment Group L.P.1,750,000$1.39M0.0%-22.2%1.686% 2/17/2025 Acuta Capital Partners LLC2,303,000$1.83M1.8%+16.4%2.219% 2/14/2025 Nantahala Capital Management LLC10,391,994$8.25M0.4%+268.5%10.012% 2/14/2025 Northern Trust Corp58,181$46K0.0%+142.4%0.056% 2/14/2025 Silverarc Capital Management LLC2,486,709$1.98M0.4%-37.8%2.396% 2/14/2025 Vivo Capital LLC9,970,152$7.92M0.9%+123.0%9.605% 2/13/2025 XTX Topco Ltd171,463$136K0.0%+142.2%0.165% 2/12/2025 Geode Capital Management LLC524,487$417K0.0%+30.3%0.505% 11/20/2024 Virtu Financial LLC73,975$30K0.0%+566.8%0.071% Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 XTX Topco Ltd70,784$29K0.0%N/A0.075% 11/14/2024 Walleye Capital LLC5,000,000$2.04M0.0%N/A5.299% 11/14/2024 Acuta Capital Partners LLC1,979,199$807K0.7%N/A2.097% 11/13/2024 Great Point Partners LLC8,559,000$3.49M1.0%N/A9.071% 10/16/2024 Bleakley Financial Group LLC80,000$33K0.0%N/A0.085% 8/20/2024 Nantahala Capital Management LLC2,820,358$1.41M0.1%-15.4%7.499% 7/12/2024 Rosalind Advisors Inc.1,571,200$787K0.6%-16.4%4.178% 5/20/2024 Virtu Financial LLC26,082$36K0.0%N/A0.069% 5/16/2024 BVF Inc. IL3,611,601$4.98M0.1%+70.5%9.603% 4/25/2024 Rosalind Advisors Inc.1,879,646$2.59M2.4%N/A5.407% 2/15/2024 BVF Inc. IL2,118,139$1.84M0.0%-37.9%6.095% 11/15/2023 RA Capital Management L.P.3,470,688$2.99M0.1%N/A9.987% 11/8/2023 Vivo Capital LLC3,470,152$2.98M0.4%N/A9.986% 8/10/2023 Ground Swell Capital LLC20,001$26K0.1%N/A0.131% 4/26/2023 Oxbow Advisors LLC11,861$25K0.0%N/A0.078% 2/15/2023 Nantahala Capital Management LLC647,416$350K0.0%-8.9%4.302% 11/15/2022 Board of Trustees of The Leland Stanford Junior University63,019$37K0.0%-74.5%0.419% 11/10/2022 Nantahala Capital Management LLC710,542$419K0.0%-2.6%4.721% 8/15/2022 Nantahala Capital Management LLC729,680$606K0.0%+13.9%4.855% 4/22/2022 Truist Financial Corp37,462$48K0.0%N/A0.250% 11/12/2021 Board of Trustees of The Leland Stanford Junior University247,583$700K0.1%N/A1.707% 11/9/2021BlackRock Inc.11,443$33K0.0%N/A0.079% 10/28/2021 Tandem Capital Management Corp ADV15,500$44K0.0%N/A0.107% (Data available from 1/1/2016 forward)Remove Ads UNCY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of UNCY shares? During the previous two years, 18 institutional investors and hedge funds held shares of Unicycive Therapeutics. The most heavily invested institutionals were Nantahala Capital Management LLC ($8.25M), Octagon Capital Advisors LP ($7.94M), Vivo Capital LLC ($7.92M), BVF Inc. IL ($4.98M), Great Point Partners LLC ($3.49M), RA Capital Management L.P. ($2.99M), and Walleye Capital LLC ($2.04M).Learn more on UNCY's institutional investors. What percentage of Unicycive Therapeutics stock is owned by institutional investors? 40.42% of Unicycive Therapeutics stock is owned by institutional investors. Learn more on UNCY's institutional investor holdings. Which institutional investors have been buying Unicycive Therapeutics stock? Of the 16 institutional investors that purchased Unicycive Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($8.97M), Great Point Partners LLC ($8.56M), Nantahala Capital Management LLC ($7.57M), Walleye Capital LLC ($5M), RA Capital Management L.P. ($3.47M), Acuta Capital Partners LLC ($2.30M), and Rosalind Advisors Inc. ($1.88M). How much institutional buying is happening at Unicycive Therapeutics? Institutional investors have bought a total of 41,217,144 shares in the last 24 months. This purchase volume represents approximately $29.12M in transactions. Which Unicycive Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Unicycive Therapeutics stock in the last 24 months: Silverarc Capital Management LLC ($1.51M), BVF Inc. IL ($1.30M), Nantahala Capital Management LLC ($515.23K), Alyeska Investment Group L.P. ($500K), and Rosalind Advisors Inc. ($308.45K). How much institutional selling is happening at Unicycive Therapeutics? Institutional investors have sold a total of 4,132,389 shares in the last 24 months. This volume of shares sold represents approximately $3.14M in transactions. Related Companies Aurora Cannabis Major Shareholders Korro Bio Major Shareholders Prime Medicine Major Shareholders Nuvectis Pharma Major Shareholders AC Immune Major Shareholders biote Major Shareholders Eledon Pharmaceuticals Major Shareholders Y-mAbs Therapeutics Major Shareholders LifeVantage Major Shareholders SOPHiA GENETICS Major Shareholders This page (NASDAQ:UNCY) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for May 7th. Because on that day, I believe we could see a $2 Trillion shock INTO the ma...Timothy Sykes | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unicycive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
